资讯

Opinion
Rio Grande Guardian8 小时Opinion
Kowalski: Why Drug Pricing Reform Must Start with PBMs—Not Price Controls
Excessive markups don’t benefit patients – they simply enrich middlemen, writes the co-chair of the We Work For Health Coalition.